EFFIK SA is a Originators company based in Nyon (Vaud) recorded by Swissmedic as the authorisation holder for 11 human medicines. That places it 136 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Nyon |
| Canton | Vaud |
| Authorisation holder | Yes |
| Medicines | 11 |
| Founded | Not available |
| Employees | 1-10 |
| Parent group | Laboratoires Effik |
| Activity | Not available |
| Website | effik.ch |
Medicines authorised in Switzerland
EFFIK SA is recorded by Swissmedic as the authorisation holder for 11 human medicines. The table shows 11 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
11 of 11 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Blissel | 62828 | B | G03CA04 | 2014-01-29 |
| Cariban 10 mg/10 mg | 67670 | B | R06AA59 | 2020-11-12 |
| Demilos 600 mg / 1000 UI | 69742 | B | A12AX | 2025-10-10 |
| Demilos 600 mg / 2000 UI | 69914 | B | A12AX | 2026-01-16 |
| Effilevo 0.10 mg / 0.02 mg | 65175 | B | G03AA07 | 2015-03-13 |
| Effilevo Conti | 65267 | B | G03AA07 | 2015-03-13 |
| Fertifol | 58121 | D | B03BB01 | 2008-02-18 |
| Hepaxane 2000 IE/UI (20 mg)/0.2 ml | 67702 | B | B01AB05 | 2021-08-12 |
| Holgyeme | 57562 | B | G03HB01 | 2006-12-13 |
| Natecal D | 61363 | D | A12AX | 2011-05-31 |
| Teglutik 50mg/10ml | 66434 | B | N07XX02 | 2018-04-26 |
Frequently asked questions
How many medicines does EFFIK SA have authorised in Switzerland?
EFFIK SA is recorded by Swissmedic as the authorisation holder for 11 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is EFFIK SA based?
The Swiss location recorded for EFFIK SA is Nyon, Vaud.
Is EFFIK SA a Swissmedic authorisation holder?
Yes. EFFIK SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.